Purpose The aim of this study was to investigate the proliferation and differentiation behaviour of a defined cell population gained from the human growth plate, namely, chondro-progenitorcells (CPCs), in the initial inflammatory phase of growth plate injury response in vitro. Methods Growth plate cells were sorted via FACS and differentiated along adipogenic and osteogenic lineage to confirm their progenitor features. To mimic the inflammatory phase of injury response at the growth plate they were treated with IL-1β and exposed to cyclic mechanical loading. A BrdU assay was used to investigate CPC proliferation. CPC differentiation behaviour was analysed by RT-PCR. Results CPCs (CD45-, CD34-, CD73+, CD90+, and CD105+) showed a successful differentiation along adipogenic and osteogenic lineage. Under conditions simulating the inflammatory phase of injury response at the growth plate in vitro CPCs differentiated towards hypertrophy while chondrogenesis and ossification were inhibited. Proliferation was not significantly altered. Conclusion This study showed that CPCs can be isolated from the human growth plate and expanded in vitro. In the first phase of injury response at the growth plate these cells differentiate towards hypertrophy. As longitudinal growth is obtained by chondrocyte proliferation and volume increase during hypertrophy this maturation might be the first step towards post-traumatic growth disorders such as unwanted premature ossification of the growth plate.
Introduction
The growth plate at the ends of long bones is a unique feature of a child's bone. This structure controls longitudinal bone growth. The growth plate contains chondrocytes at different stages of differentiation, which are organised into several zones: resting, proliferative, pre-hypertrophic and hypertrophic. Within the growth plate, enchondral ossification occurs, which gradually converts cartilage into bone [1] . This well orchestrated process can be easily disrupted by fractures involving the growth plate. If large enough, such fractures impair the growth process, leading to growth disorders due to destruction of the epiphyseal circulation and formation of a bone bridge [2] . A bone bridge evokes limb length discrepancies and predisposes to angular deformity, as the chondrocytes of the remaining parts of the growth plate continue the normal growth process [3] .
Following a growth plate injury four different phases of injury response have been identified in various animal models. The first response is the inflammatory phase, followed by the fibrogenic phase, where stromal progenitor cells infiltrate the injury site. During the osteogenic and maturation phases bone cells differentiate and form bony tissue [4] . The molecular and cellular mechanisms regulating these injury healing phases at the growth plate, however, have not been clarified yet.
During the inflammatory phase of injury response the growth plate is influenced mainly by two stimuli: (1) highly up-regulated pro-inflammatory cytokines and (2) differential mechanical loading forces in terms of micro-movements occur at the injury site, even if the fracture is osteosynthetically stabilised. Pro-inflammatory cytokines stimulate the remodelling of the extracellular matrix and cell differentiation towards both osteogenic and chondrogenic lineages [5, 6] . Mechanical stimuli influence growth plate chondrocyte metabolism, dependent on loading type and frequency [7] .
The aim of our study was to mimic for the first time the initial inflammatory phase of injury response at the growth plate in vitro, and to investigate under these conditions the proliferation and differentiation behaviour of a defined cell population gained from the human growth plate, namely, chondro-progenitorcells (CPCs). Thus, we isolated cells from the human growth plate and sorted them via FACS in order to obtain CPCs. These CPSs were treated with IL-1β and exposed to cyclic mechanical loading using the Flexcell Tension Plus System 3000 (FlexcellInt, Hillsborough, NC) to simulate the up-regulation of inflammatory cytokines and the presence of micro-movements at the injury site, respectively. Proliferation behaviour of CPCs was then analysed with a BrdU proliferation assay and mRNA expression of the main chondrogenic and osteogenic marker genes was investigated in a RT-PCR. We expected both mechanical and inflammatory stimuli to greatly influence CPC proliferation and differentiation.
Material and methods

Cell culture
Samples of the infant growth plate were obtained from the supernumerary digit of eight different donors with polydactylism at the time of surgical excision. The study protocol was approved by the local ethics committee (EK-No. 20-344 ex 08/09). Growth plate tissue was digested in 300 units/ml collagenase B (Worthington Biochemical Corp., Lakewood, NJ) overnight, and then 6×10 5 cells were re-suspended in growth medium (DMEM/F-12 1:1 supplemented with 5 % FCS, 1 % penicillin/streptomycin and 0.1 % Amphotericin B; all reagents from Invitrogen, Carlsbad, CA) and seeded into a 75 cm² flask. After one to three passages, cells were harvested and sorted via fluorescence-activated cell sorting (FACS). All experiments were performed under standard cell culture conditions of 37°C, 5 % CO 2 .
Cell sorting
Up to 5×10 6 cells from growth plate cartilage were incubated with primary conjugated antibodies specific for CD45-APCCy™7, CD34-APC, CD73-PE (all BD Bioscience, San Diego, CA), CD90-FITC, or CD105-PerCP/Cy5.5 (both BioLegend, San Diego, CA) for one hour at 4°C. Labeled cells were resuspended in PBS and subjected to FACS (BD FACSAria, BD Bioscience, Heidelberg, Germany). The appropriate IgG controls were run in parallel. Sorted CPCs were expanded in growth medium.
Osteogenic and adipogenic lineage differentiation
In order to confirm their progenitor features, CPCs were subjected to adipogenic and osteogenic lineage differentiation. CPCs were kept in adipogenic or osteogenic differentiation medium (STEMPRO® Adipocyte/Osteocyte Differentiation Medium, Invitrogen) for 21 days respectively. To evaluate lipid droplet formation, cells were fixed in 10 % formaldehyde and stained with Oil Red O for one hour (SigmaAldrich, Vienna, Austria). To evaluate the mineralised matrix an alkaline phosphatase (ALP) staining was performed. Cells were fixed in 10 % formaldehyde and stained with a solution of naphtol As-MX-PO 4 and Fast red violet LB salt (both Sigma-Aldrich) for 45 min.
Mimicking the inflammatory phase of injury response at the growth plate in vitro CPCs in the first to third passages were used in this experiment. Cells for the control and experimental conditions were at the same passage number. Four groups were analysed: mechanical loaded CPCs (ML), mechanical loaded CPCs treated with IL-1β (ML/IL-1β), CPCs treated with IL-1β (IL-1β), and untreated CPCs (control). A total of 1.5×10 5 CPCs/well were seeded in collagen I coated flexible-bottomed culture plates (Flexcell Int) and incubated for 24 hours. One hour prior to mechanical loading 2-ng human recombinant IL-1β/ml media (Sigma-Aldrich) were added to the wells of the corresponding groups. The Flexcell Tension Plus System 3000 (Flexcell Int) was then used to apply cyclic mechanical stretching with 3 % surface elongation at 0.1 Hz for five days, which was considered being representative for micro-movements [8] . The experiment was run in triplicate.
BrdU proliferation assay CPC proliferative activity was measured following IL-1β treatment and/or mechanical loading based on the BrdU incorporation during DNA synthesis using a commercial chemiluminescent BrdU ELISA kit (Roche Molecular Biochemicals, Vienna, Austria) according to the manufacturer's instructions.
Real time RT-PCR
Following IL-1β treatment and/or mechanical loading total RNA was extracted with an RNeasy Mini Kit (Qiagen, Hilden, Germany) and reverse transcribed using the RevertAid cDNA Synthesis Kit (Fermentas) according to the manual. Real-time RT-PCR reactions were performed and monitored using the Light Cycler LC480 instrument (Roche Diagnostics). cDNA samples were analysed in triplicate. Sequences of primers for the reference gene (β-actin) and genes of interest, i.e. Sox9, type II collagen (Col2a1), aggrecan (ACAN), Runx2, type X collagen (Col10a1) and osteocalcin, are listed in Table 1 . All primers were provided from MWG, Ebersberg, Germany. Results were normalised to β-actin levels using the formula ΔCt (threshold cycle)0Ct of target gene − Ct of β-actin. The comparative Ct method was used to investigate the amount of target gene relative to the calibrator. All graphs demonstrate the fold change and its range of each experimental group when the control group was normalised as 1.
Statistical analysis
For statistical analysis SPSS® 18.0 software (SPSS Inc., Chicago) was used. Possible statistical significance comparing the groups in terms of proliferation was analysed by Friedman's test. To determine statistically significant gene expression differences analysed by real time RT-PCR, the Wilcoxon signed-rank test was performed. A p-value <0.05 was considered significant.
Results
Samples
Growth plate cells from eight different donors were selected for the study. Ages ranged from 0.25 years to 2.3 years (mean ± SD, 1.14±0.68 years) with no significant difference between males and females. CPCs showed the following surface protein expression profile previously described to be characteristic for progenitor cells [9] : CD45−, CD34−, CD73+, CD90+, and CD105+ (Fig. 1) .
CPCs from the human growth plate are inducible to osteogenic and adipogenic lineage differentiation After a period of 21 days CPCs subjected to adipogenic differentiation demonstrated scattered aggregates of positive Oil Red O stained cells in the experimental group (Fig. 2a) , which were absent in the control group (Fig. 2b) . CPCs subjected to osteogenic differentiation stained clearly positive for ALP (Fig. 2c) , whereas no expression of this enzyme could be observed in control groups (Fig. 2d) .
Mechanical loading and IL-1β treatment did not alter CPC proliferation significantly compared to control
The BrdU immunoassay showed that IL-1β promotes proliferation of CPCs when compared to mechanical loading (Fig. 3) . However, proliferation of CPCs that were exposed to both mechanical loading and IL-1β did not significantly differ from control CPCs.
Under conditions simulating inflammatory injury response at the growth plate in vitro CPCs differentiate towards hypertrophy
To examine the effects of mechanical loading and IL-1β on the differentiation behavior of CPCs, mRNA expression of the main markers for chondrogenesis, hypertrophy and osteogenesis was investiagted by real-time RT-PCR. As markers for chondrogenesis we evaluated expression of Sox9 (Fig. 4a) , the main chondrogenic differentiation transcription factor, as well as expression of type II collagen (Fig. 4b) and aggrecan (Fig. 4c) , both cartilage-specific matrix molecules. Our results showed a significant down-regulation of Sox9 in the study groups IL-1 and ML/IL-1 compared to control (Fig. 4a) . As markers for hypertrophy and osteogenesis type X collagen (Fig. 4e), Runx2 (Fig. 4d) and osteocalcin (Fig. 4f) were analysed. Our results showed a dramatic up-regulation of type X collagen in the study groups IL-1 and ML/IL-1 compared to control (Fig. 4e) . In these same study groups expression of osteocalcin was significantly down-regulated (Fig. 4f) .
Discussion
This study showed for the first time that CPCs can be isolated from the human growth plate, expanded in vitro and differentiated along osteogenic and adipogenic lineage (Fig. 2a-d) . Conditions simulating the inflammatory phase of injury response at the growth plate in vitro did not affect human CPC proliferation (Fig. 3) . Under such conditions, CPCs differentiated towards hypertrophy, while chondrogenesis and ossification were inhibited (Fig. 4a-f ).
To our knowledge this is the first in vitro study on primary human growth plate cells. Being of human origin and thereby showing normal biological variability, these cells make results more comparable to the human body than In our experiments we used chondro-progenitorcells, a defined cell population obtained from the human growth plate. These cells have the highest proliferation and differentiation potential within the growth plate [10] . We therefore postulated that they would contribute to a major extent to the healing process of a growth plate injury.
Our data shows that under conditions simulating the inflammatory phase of injury response at the growth plate CPC proliferation is not affected. Interestingly, we discovered that inflammatory and mechanical stimuli have a contrasting effect on CPC proliferation, with IL-1β promoting it and mechanical loading inhibiting it. The phenomenon of overgrowth due to inflammatory stimuli has clinically been reported in children suffering from pauci-articular juvenile rheumatoid arthritis. In these children an increased longitudinal bone growth was seen in the affected limbs. However, overgrowth was dependent on the patients' age and the disease' onset, with only young children showing limb overgrowth [11, 12] . In our study the donor's age was not above four years, leaving the possibility that the proproliferative effect of IL-1β and the consequent contrasting effect to mechanical loading were related to donors age. Mechanical loading, i.e. tensile strain, was reported to enhance proliferation within the growth plate [13] . This, however, has been shown to be dependent on the loading frequency [7] . In our experiments we exposed CPCs from the human growth plate to a relatively low loading frequency of 0.1 Hz and a surface elongation of 3 %. This mechanical stimuli showed an inhibitory effect on CPC proliferation. Our loading protocol was chosen because it represented less than physiological locomotion [8] and therefore best mimics the situation after growth plate fracture, when the affected limb is immobilised and only micro-movements remain present at the injury site.
Our study indicated that under conditions simulating the inflammatory phase of injury response at the growth plate in vitro chondrogenesis and ossification are inhibited while differentiation towards hypertrophy of CPCs is dramatically promoted. The inhibition of chondrogenesis and ossification is reflected in the down-regulation of Sox9, the main chondrogenic differentiation transcription factor [14] and the down-regulation of osteocalcin. Osteocalcin is involved in the calcification of hypertrophic cartilage matrix [15] . In this study the inhibition of chondrogenesis and ossification was shown to be almost exclusively the effect of inflammatory stimuli, as CPCs exposed to mechanical loading did not show any significant difference in gene expression compared to the control. This result agrees with literature; under inflammatory conditions chondrogenesis is inhibited [11, 14] and longitudinal bone growth in children is delayed [11, 16] . Differentiation of CPCs towards hypertrophy under mechanical loading and IL-1β treatment in vitro resulted in a significant increase in type X collagen expression. Type X collagen is a specific marker for hypertrophy of growth plate chondrocytes [17] . Hypertrophic maturation of growth plate chondrocytes is responsible for up to 60 % of longitudinal bone growth [18] and represents the last differentiation step before the cells enter the process of apoptosis and allow invading osteoblasts to deposit osteoid and to form bone. An increased expression of type X collagen has already been reported in chondrocytes under the influence of pro-inflammatory cytokines [19] . Interestingly, in our study mechanical loading potentiated the effect of IL-1β. This was unexpected, as mechanical loading of low magnitudes has been reported to act as an antagonist of IL-1β, i.e. inhibiting IL-1β's catabolic effects [20, 21] . However, in this particular context our results indicate the opposite. They suggest that hypertrophy of growth plate cells might be the first step towards a disturbed longitudinal growth and an unwanted pre-mature ossification of the growth plate, as it may occur after growth plate injuries. Clinically, this finding indicates that reducing the local amount of inflammatory cytokines could be one possible target therapy to prevent the unwanted process of premature growth plate hypertrophy and subsequent ossification. To analyse this, future studies focussing on CPC behaviour under anti-inflammatory and different controlled mechanical loading conditions in this delicate early phase of injury response at the growth plate are planned. We believe that the ability to manipulate CPCs in an early phase of injury response may provide a powerful and adaptable tool to prevent complications of growth plate injuries, as formation of a bone bridge or angular deformity in children.
Conclusion
This study showed for the first time that CPCs can be isolated from the human growth plate, expanded in vitro and differentiated along osteogenic and adipogenic lineage. Furthermore the study showed that in the first phase of injury response at the growth plate CPCs differentiate towards hypertrophy, proliferation remains unaffected and chondrogenesis and ossification are inhibited. This reaction of CPCs might be the first step towards an unwanted premature ossification of the growth plate.
